Compare Organon & Co. Common Stock (OGN) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.01 (market cap $330.26M). The key difference: Organon & Co. Common Stock is far larger — about 11× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 56 Days on average.
| OGN | XDTE | |
|---|---|---|
Market Cap | $3.62B | $330.26M |
Volume | 2,892,999 | 54,618 |
Sector | Health | Income / Options Overlay |
52-Week High | $13.81 | $44.76 |
52-Week Low | $5.70 | $36.00 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $11.04B | — |
Dividend Yield | 0.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
XDTE (Roundhill S&P 500 0DTE Covered Call Strategy ETF) trades at $38.70 with no recent price movement. The technical picture appears bearish with moving averages signaling caution, while oscillators remain neutral. Recent news highlights concerns about the sustainability of XDTE's high yield strategy, with multiple articles questioning whether dividend payments represent true income or return of capital. The fund's weekly dividend payments range from $0.09 to $0.20, but analysts express skepticism about the underlying math.
The outlook for XDTE remains cautious as structural concerns about its covered call strategy persist. While the fund offers attractive weekly income, questions about yield sustainability and fee efficiency present significant risks. Investors should weigh the trade-offs between immediate income generation and potential long-term capital appreciation limitations in flat or rising markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
